Includes pharmaceutical, herbal and street drugs by four classes and combinations, with molecular structure, links to additional information, and, for brand name drugs, indications and approval dates.
FDA Drug News
- 8.27.2019 Nourianz for Parkinson's
- 6.21.2019 Vyleesi for Female Hypoactive Sexual Desire Disorder
- 5.24.2019 Vraylar for bipolar depression
- 5.17.2019 Nayzilam for epilepsy